-
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
The influence of parity and gravidity on first trimester markers of chromosomal abnormality.
Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:792-4. -
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Spencer K, Heath V, Flack N, Ong C, Nicolaides KH.
Prenat Diagn 2000;20:635-9. -
The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities.
Spencer K, Ong CY, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:491-4. -
Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester.
Spencer K, Tul N, Nicolaides KH.
Prenat Diagn 2000;20:390-4. -
One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester.
Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH.
BJOG 2000;107:1271-5. -
Semiquantitative immunohistochemical localisation of PAPP-A and beta-hCG in first trimester chorionic villi from euploid and trisomic pregnancies.
Sebire NJ, Roberts L, Nicolaides KH.
J Pathol 2000;192:30. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38. -
Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.
Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH.
BJOG 1997;104:741-3. -
Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks gestation)
Macintosh MC, Nicolaides KH, Noble P, Chard T, Gunn L, Illes R.
Prenat Diagn 1997;17:401-5. -
Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18.
Jauniaux E, Nicolaides KH, Nagy AM, Brizot M, Meuris S.
J Endocrinol 1996;148:27-31. -
Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies.
Brizot ML, Hyett JA, Mckie AT, Bersinger NA, Farzaneh F, Nicolaides KH.
Placenta 1996;17:33-6. -
Maternal serum concentrations of pregnancy associated plasma protein A and pregnancy specific B-1 glycoprotein in multifetal pregnancies before and after fetal reduction.
Abbas A, Sebire NJ, Johnson M, Bersinger N, Nicolaides KH.
Hum Reprod 1996;11,900-2. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Neutrophil and monocyte beta 2-integrin expression in trisomic fetuses.
Makrydimas G, Thilaganathan B, Plachouras N, Nicolaides KH.
Prenat Diagn 1995;15:325-7. -
Maternal serum Schwangerschafts protein-1 (SP1) and fetal chromosomal abnormalities at 10-13 weeks' gestation.
Brizot ML, Bersinger NA, Xydias G, Snijders RJ, Nicolaides KH.
Early Hum Dev 1995;43:31-6. -
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML, Snijders RJ, Butler J, Bersinger NA, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:127-32. -
Fetal and maternal hCG concentration in aneuploid pregnancies.
Abbas A, Chard T, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:561-3.